Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Florbetaben F-18 in Alzheimer Disease: NCT07169630 Clinical Landscape Report 2026
16 October 2026
NCT07169630 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Trontinemab in Alzheimer Disease: NCT07169578 Clinical Landscape Report 2026
16 October 2026
NCT07169578 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Tadalafil in Alzheimer Disease: NCT07172815 Clinical Landscape Report 2026
16 October 2026
NCT07172815 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Emapunil in Alzheimer Disease: NCT07191821 Clinical Landscape Report 2026
16 October 2026
NCT07191821 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Recombinant human erythropoietin(Center of Molecular Immunology) in Alzheimer Disease: NCT07178678 Clinical Landscape Report 2026
16 October 2026
NCT07178678 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Protollin in Alzheimer Disease: NCT07187141 Clinical Landscape Report 2026
16 October 2026
NCT07187141 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Icotrokinra Hydrochloride in Colitis, Ulcerative: NCT07196748 Clinical Landscape Report 2026
16 October 2026
NCT07196748 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
MLC901 in Alzheimer Disease: NCT07191028 Clinical Landscape Report 2026
16 October 2026
NCT07191028 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Semaglutide (Novo Nordisk) in Alzheimer Disease: NCT07200622 Clinical Landscape Report 2026
16 October 2026
NCT07200622 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Icotrokinra Hydrochloride in Crohn Disease: NCT07196722 Clinical Landscape Report 2026
16 October 2026
NCT07196722 clinical landscape for Crohn Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Autologous Adipose-Derived Stem Cells(Regeneration Biomedical, Inc.) in Alzheimer Disease: NCT07205601 Clinical Landscape Report 2026
16 October 2026
NCT07205601 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Emtricitabine/Tenofovir Alafenamide Fumarate in Alzheimer Disease: NCT07210528 Clinical Landscape Report 2026
16 October 2026
NCT07210528 clinical landscape for Alzheimer Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.